OrbomedEARLY DIAGNOSIS – TIMELY CURE
Orbomed teamVitaly Vishnepolsky, MBA           CEO             Dr. Vadim Sigalov, MDChief Business consultant             ...
Hysteroscopy: background• Gold standard for detection  of intrauterine pathology• Safe and simple procedure  for outpatien...
Hysteroscopy: background (cont.)• From patients’ side pain continues to  represent the main limiting factor to a  large-sc...
Office Based Hysteroscopy(OBH) facts• Only 15% of gynecologists in the United States  routinely perform office hysteroscop...
The OBH need• Broadening of applications’ list• Cost reduction• Becoming the gold standard  for specific operations• Updat...
Orbomed:Office Based Hysteroscopy product line•   Three dimensional scissors•   No need for laparoscop reposition•   Easie...
Advantages of Orbomed•   Improved patient’s comfort•   Eliminated need for general anesthesia•   Shorten interventional pr...
Target CustomersPrivate/public gynecological clinics
Applications• Polypectomy – 6M of annual visits• Adhesiolysis – 1M of Asherman Syndrome• Biopsy under direct visualization...
Market potential•   Global Uro-Gynecological    Surgical Devices Market to    Reach US$1.98 Billion by    2015•   Global B...
Orbomed R&D plan• Within 24 months we plan to achieve fully  working prototype ready for clinical trials• Planned budget $...
‫‪Budget‬‬                          ‫שיווק‬          ‫שונות‬            ‫%9‬   ‫ציוד‬   ‫%31‬                             ...
Thank you
Orbomed - office based hysteroscopy
Upcoming SlideShare
Loading in...5
×

Orbomed - office based hysteroscopy

426

Published on

Published in: Health & Medicine
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
426
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Orbomed - office based hysteroscopy

  1. 1. OrbomedEARLY DIAGNOSIS – TIMELY CURE
  2. 2. Orbomed teamVitaly Vishnepolsky, MBA CEO Dr. Vadim Sigalov, MDChief Business consultant Chief Medical consultant Ksenia Chagan, MBA Igor Shcherback, PhD Biotech advisor Physics advisor
  3. 3. Hysteroscopy: background• Gold standard for detection of intrauterine pathology• Safe and simple procedure for outpatient clinics
  4. 4. Hysteroscopy: background (cont.)• From patients’ side pain continues to represent the main limiting factor to a large-scale use of outpatient hysteroscopy
  5. 5. Office Based Hysteroscopy(OBH) facts• Only 15% of gynecologists in the United States routinely perform office hysteroscopy to evaluate intrauterine pathology. Reimbursement Equipment
  6. 6. The OBH need• Broadening of applications’ list• Cost reduction• Becoming the gold standard for specific operations• Updating of reimbursement policies.
  7. 7. Orbomed:Office Based Hysteroscopy product line• Three dimensional scissors• No need for laparoscop reposition• Easier lesion capture in moving media (saline flow)• Ready-for-sending tissue sample post-operationally
  8. 8. What is the difference inORBOMED concept?VIDEO>>
  9. 9. Advantages of Orbomed• Improved patient’s comfort• Eliminated need for general anesthesia• Shorten interventional procedure• Reduced overall cost
  10. 10. Target CustomersPrivate/public gynecological clinics
  11. 11. Applications• Polypectomy – 6M of annual visits• Adhesiolysis – 1M of Asherman Syndrome• Biopsy under direct visualization – approx. 50K of new endometrial cancer/year
  12. 12. Market potential• Global Uro-Gynecological Surgical Devices Market to Reach US$1.98 Billion by 2015• Global Biopsy devices Market is expected to reach $1.4 Billion by 2018, CAGR 5% from 2011.
  13. 13. Orbomed R&D plan• Within 24 months we plan to achieve fully working prototype ready for clinical trials• Planned budget $750K
  14. 14. ‫‪Budget‬‬ ‫שיווק‬ ‫שונות‬ ‫%9‬ ‫ציוד‬ ‫%31‬ ‫שכר‬ ‫%3‬ ‫%24‬ ‫קבלני משנה‬ ‫%92‬ ‫חומרים וציוד‬ ‫מתכלה‬ ‫%4‬
  15. 15. Thank you

×